AHR and prostate carcinoma: Studies in the transgenic, androgen-sensitive TRAMP model of prostate cancer show that AhR protects against prostate cancer development, as AHR+/+ TRAMP mice exhibit lower tumor formation than AHR-/- or AHR+/- TRAMP mice (74).